The EPO published Smith & Nephew's patent application EP3941346A1 for systems and methods measuring tissue impedance. The invention, classified under A61B 5/053 and A61B 5/00, covers diagnostic technology that measures electrical impedance of biological tissues. Designated states include all EU member states plus other European countries including the UK, Switzerland, and Norway.

Patent publications do not create compliance obligations or deadlines for regulated entities. Medical device manufacturers developing tissue characterization or diagnostic equipment should review the published claims to assess potential patent landscape implications or freedom-to-operate considerations. No action is required for standard compliance programs.